Hardie Grace E, Gold Warren M, Janson Susan, Carrieri-Kohlman Virginia, Boushey Homer A
Department of Nursing, The University of California at San Francisco, USA.
J Asthma. 2002 Oct;39(7):611-8. doi: 10.1081/jas-120014925.
The way, or ways, in which asthmatics recognize specific symptom(s) with varying degrees of their airway obstruction, or asthma severity, is poorly understood. Our purpose was to gain a better understanding of how asthma patients during acute episodes, based on their symptom perception, decide when to seek symptom relief. A cross-sectional design was used to study 32, 16 per group, African Americans and Caucasians with a mean age of 34.5 years. All had mild, stable asthma (FEV1 > or = 70%), were non-smokers, atopic, and had not used inhaled or oral steroids for 3 months. Their mean baseline FEV1 was 97.5% predicted; all were controlled with intermittent use of a beta agonist inhaler. All had a bronchoconstrictor challenge using a provocative concentration of methacholine to achieve a 30% fall (PC30) in their FEV1. After achieving a PC30 and before their first dose of a bronchodilator was given, all subjects were asked: "If you felt this way at home would you take your inhaler?" Subjects were blinded to the fact that the yes/no question was asked when their FEV1 was reduced by 30%. In both groups, 44% responded "no" that they would not use their inhaler at that point in time. This finding suggests that those subjects, the 44% who failed to associate a change in their symptoms with increased airflow obstruction, may be at risk for life-threatening episodes.
哮喘患者识别特定症状与不同程度气道阻塞或哮喘严重程度之间的方式,目前了解甚少。我们的目的是更好地了解哮喘患者在急性发作期间,基于其症状感知,如何决定何时寻求症状缓解。采用横断面设计研究了32名患者,每组16名,为非裔美国人和白种人,平均年龄34.5岁。所有患者均患有轻度、稳定型哮喘(FEV1≥70%),不吸烟,有特应性,且3个月内未使用吸入或口服类固醇。他们的平均基线FEV1为预测值的97.5%;所有患者通过间歇性使用β受体激动剂吸入器得到控制。所有患者均使用激发浓度的乙酰甲胆碱进行支气管收缩激发试验,以使FEV1下降30%(PC30)。在达到PC30后且在给予第一剂支气管扩张剂之前,所有受试者被问及:“如果你在家有这种感觉,会使用吸入器吗?”受试者对在FEV1下降30%时被问及是/否问题这一事实不知情。在两组中,44%的受试者回答“不会”,即在那个时间点不会使用吸入器。这一发现表明,那些未能将症状变化与气流阻塞增加联系起来的受试者,即44%的受试者,可能面临危及生命发作的风险。